| Literature DB >> 29759532 |
Hans Kottkamp1, Doreen Schreiber2, Fabian Moser2, Andreas Rieger2.
Abstract
Atrial fibrosis is the fundamental histopathologic finding in atrial fibrillation (AF) patients and an important predictor of ablation failure beyond pulmonary vein isolation. There is wide variation in the extent and localization of left atrial fibrosis in patients with paroxysmal and nonparoxysmal AF. Box isolation of fibrotic areas is an effective rhythm control concept in patients with paroxysmal AF despite durable pulmonary vein isolation, and this strategy has recently been implemented successfully in initial AF ablation procedures in addition to pulmonary vein isolation for patients with nonparoxysmal AF. In contrast, the time for "empirical" lines or other nonindividualized substrate modifications seems over.Entities:
Keywords: atrial fibrillation; atrial fibrosis; catheter ablation; fibrotic atrial cardiomyopathy; risk factor; substrate modification
Mesh:
Year: 2017 PMID: 29759532 DOI: 10.1016/j.jacep.2017.05.009
Source DB: PubMed Journal: JACC Clin Electrophysiol ISSN: 2405-500X